Site icon Indonesian Updates

President lauds ACF-A’s role in developing COVID-19 vaccines

Thank you, the WHO director general for your invitation. I highly appreciate ACT-A’s role in encouraging the development of and fair access to COVID-19 drugs, diagnosis devices, and vaccines

Jakarta (ANTARA) – Indonesian President Joko Widodo has lauded the role played by the Access to COVID-19 Tools Accelerator (ACT-A) in encouraging the development of COVID-19 drugs, tools, and vaccines.

“Thank you the WHO (World Health Organization) director general for your invitation. I highly appreciate ACT-A’s role in encouraging the development of and fair access to COVID-19 drugs, diagnosis devices, and vaccines,” he remarked in a virtual address at the ACT-Accelerator Campaign 2022, accessed through the Youtube channel of the Presidential Secretariat on Wednesday night.

Related news: Merah Putih vaccine to be used as booster, child vaccine: Minister

ACT-A is an essential part of the global health architecture and concrete proof of the benefits of multilateralism, he said.

Looking ahead, ACT-A’s role will still be badly needed, particularly to bridge global vaccine inequality, Widodo added.

Related news: Indonesia highlights global vaccine equality to tackle COVID-19

“No one is safe until everyone is. I call on countries and donors to use this opportunity to strengthen their support for ACT-A,” he said.

During its G20 Presidency, Indonesia will strengthen global health architecture as one of its priority agendas, he added.

Related news: Indonesia committed to protecting foreign refugees: Minister

Related news: Merah Putih Vaccine included in super-priority program by Jokowi

Exit mobile version